首页> 外国专利> USE OF A PHOTOACTIVE COMPOUND FOR THE MANUFACTURE OF A MEDICAMENT FOR ENHANCEMENT OF VISUAL ACTIVITY, COMBINED WITH IRRADIATING THEREAFTER TARGET OCULAR TISSUE WITH LIGHT ABSORBED BY A PHOTOACTIVE COMPOUND

USE OF A PHOTOACTIVE COMPOUND FOR THE MANUFACTURE OF A MEDICAMENT FOR ENHANCEMENT OF VISUAL ACTIVITY, COMBINED WITH IRRADIATING THEREAFTER TARGET OCULAR TISSUE WITH LIGHT ABSORBED BY A PHOTOACTIVE COMPOUND

机译:使用光敏化合物制造增强视力的药物,并结合用光吸收性化合物吸收的更好的目标眼组织进行光照射

摘要

Photodynamic therapy of conditions of the eye, especially those conditions characterized by unwanted neovasculature, such as age-related macular degeneration, results in enhanced visual acuity for treated subjects.
机译:眼部疾病的光动力疗法,特别是那些以不希望的新脉管系统为特征的疾病,例如与年龄有关的黄斑变性,对治疗对象的视力增强。

著录项

  • 公开/公告号IL187758B

    专利类型

  • 公开/公告日2011-05-31

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;QLT INC.;

    申请/专利号IL187758

  • 发明设计人

    申请日2007-11-29

  • 分类号A61K9/127;A61Knull/null;A61K31/00;A61K31/40;A61K31/409;A61K41/00;A61K45/00;A61P27/00;A61P27/02;

  • 国家 IL

  • 入库时间 2022-08-21 18:06:19

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号